Clinical Trial Update: A Study of Single and Multiple Doses of LP-003 in Healthy Adult Participants [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating single and multiple doses of LP-003 in healthy adult participants has completed, focusing on safety, tolerability, and pharmacokineti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spontaneous Urticaria

Drugs mentioned

• LP-003

Snippet

Sponsor: Longbio Pharma | Conditions: Chronic Spontaneous Urticaria | Phase 1 | Status: COMPLETED